1. 2022
  2. Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group

    HOVON CLL study group, 2022, In: Leukemia & lymphoma. 63, 10, p. 2276-2289 14 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  3. SARS-CoV-2 hyperimmune globulin for severely immunocompromised patients with COVID-19: a randomised, controlled, double-blind, phase 3 trial

    Huygens, S., Hofsink, Q., Nijhof, I. S., Goorhuis, A., Kater, A. P., te Boekhorst, P. A., Swaneveld, F., Novotny, V. M., Bogers, S., Welkers, M. R., Papageorgiou, G., Rijnders, B. J., Heijmans, J. & Heijmans, J., 2022.

    Research output: Working paperPreprint

  4. 2021
  5. Combined ibrutinib and venetoclax treatment vs single agents in the TCL1 mouse model of chronic lymphocytic leukemia

    Kater, A. P., Slinger, E., Cretenet, G., Martens, A. W., Balasubramanian, S., Leverson, J. D. & Eldering, E., 14 Dec 2021, In: Blood advances. 5, 23, p. 5410-5414 5 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Treatment Approaches to Chronic Lymphocytic Leukemia With High-Risk Molecular Features

    van der Straten, L., Hengeveld, P. J., Kater, A. P., Langerak, A. W. & Levin, M-D., 9 Dec 2021, In: Frontiers in oncology. 11, 780085.

    Research output: Contribution to journalReview articleAcademicpeer-review

  7. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

    Chatzikonstantinou, T., Kapetanakis, A., Scarfò, L., Karakatsoulis, G., Allsup, D., Cabrero, A. A., Andres, M., Antic, D., Baile, M. N., Baliakas, P., Bron, D., Capasso, A., Chatzileontiadou, S., Cordoba, R., Correa, J-G., Cuéllar-García, C., de Paoli, L., de Paolis, M. R., del Poeta, G., Demosthenous, C., & 93 othersDimou, M., Donaldson, D., Doubek, M., Efstathopoulou, M., Eichhorst, B., el-Ashwah, S., Enrico, A., Espinet, B., Farina, L., Ferrari, A., Foglietta, M., Frederiksen, H., Fürstenau, M., García-Marco, J. A., García-Serra, R., Gentile, M., Gimeno, E., Glenthøj, A., Gomes da Silva, M., Gutwein, O., Hakobyan, Y. K., Herishanu, Y., Hernández-Rivas, J. Á., Herold, T., Innocenti, I., Itchaki, G., Jaksic, O., Janssens, A., Kalashnikova, О. B., Kalicińska, E., Karlsson, L. K., Kater, A. P., Kersting, S., Labrador, J., Lad, D., Laurenti, L., Levin, M-D., Lista, E., Lopez-Garcia, A., Malerba, L., Marasca, R., Marchetti, M., Marquet, J., Mattsson, M., Mauro, F. R., Milosevic, I., Mirás, F., Morawska, M., Motta, M., Munir, T., Murru, R., Niemann, C. U., Rodrigues, R. N., Olivieri, J., Orsucci, L., Papaioannou, M., Pavlovsky, M. A., Piskunova, I., Popov, V. M., Quaglia, F. M., Quaresmini, G., Qvist, K., Reda, G., Rigolin, G. M., Ruchlemer, R., Saghumyan, G., Shrestha, A., Šimkovič, M., Špaček, M., Sportoletti, P., Stanca, O., Stavroyianni, N., Tadmor, T., te Raa, D., Tonino, S. H., Trentin, L., van der Spek, E., van Gelder, M., van Kampen, R., Varettoni, M., Visentin, A., Vitale, C., Wasik-Szczepanek, E., Wróbel, T., San Segundo, L. Y. Ñ., Yassin, M., Coscia, M., Rambaldi, A., Montserrat, E., Foà, R., Cuneo, A., Stamatopoulos, K. & Ghia, P., Dec 2021, In: Leukemia. 35, 12, p. 3444-3454 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

    Byrd, J. C., Hillmen, P., Ghia, P., Kater, A. P., Chanan-Khan, A., Furman, R. R., O'Brien, S., Yenerel, M. N., Illés, A., Kay, N., Garcia-Marco, J. A., Mato, A., Pinilla-Ibarz, J., Seymour, J. F., Lepretre, S., Stilgenbauer, S., Robak, T., Rothbaum, W., Izumi, R., Hamdy, A., & 4 othersPatel, P., Higgins, K., Sohoni, S. & Jurczak, W., 1 Nov 2021, In: Journal of clinical oncology. 39, 31, p. 3441-3452 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  9. Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?

    Al-Sawaf, O., Seymour, J. F., Kater, A. P. & Fischer, K., Aug 2021, In: Hematology/oncology clinics of North America. 35, 4, p. 775-791 17 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  10. Co-stimulatory versus cell death aspects of agonistic cd40 monoclonal antibody selicrelumab in chronic lymphocytic leukemia

    Delgado, R., Kielbassa, K., ter Burg, J., Klein, C., Trumpfheller, C., de Heer, K., Kater, A. P. & Eldering, E., 2 Jun 2021, In: Cancers. 13, 12, 3084.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective

    Peters, F. S., Strefford, J. C., Eldering, E. & Kater, A. P., 1 May 2021, In: Haematologica. 106, 5, p. 1234-1243 10 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...20 Next

ID: 64520